Data / Form D filings / Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc.: Form D filings
Minerva Neurosciences, Inc., a biotechnology company in Burlington, MA, filed 3 Form D notices with the SEC between 2015 and 2023. The latest, on July 3, 2023, reports an offering of $20 million with nothing sold yet to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1500 District Avenue, Burlington, MA, 01803
- Phone
- (617) 600-7373
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1598646
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 3, 2023 | New notice | $19,999,994 | $0 | $19,999,994 | 4 | Jun 30, 2023 | sec.gov |
| Mar 18, 2016 | New notice | $1,000,000 | $1,000,000 | 1 | Mar 17, 2016 | sec.gov | |
| Mar 24, 2015 | New notice | $30,999,997 | $30,999,997 | 22 | Mar 18, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Fouzia Peter Laghrissi-Thode | Director | |
| Jan Peter van Heek | Director | |
| David Peter Kupfer | Director | |
| Jeryl Peter Hilleman | Director | |
| Hans Peter Hasler | Director | |
| Geoffrey Race | Executive Officer | |
| Remy Luthringer | Executive Officer, Director | |
| Frederick Ahlholm | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 3, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Minerva Neurosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.